PMC:7253482 / 25985-26192 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"830","span":{"begin":20,"end":25},"obj":"Species"},{"id":"831","span":{"begin":3,"end":9},"obj":"Chemical"}],"attributes":[{"id":"A830","pred":"tao:has_database_id","subj":"830","obj":"Tax:11676"},{"id":"A831","pred":"tao:has_database_id","subj":"831","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T143","span":{"begin":20,"end":23},"obj":"Body_part"}],"attributes":[{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T161","span":{"begin":80,"end":85},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T162","span":{"begin":148,"end":155},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T81","span":{"begin":80,"end":85},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T82","span":{"begin":148,"end":155},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}

    LitCovid-sample-Enju

    {"project":"LitCovid-sample-Enju","denotations":[{"id":"T10675","span":{"begin":3,"end":9},"obj":"NN"},{"id":"T18714","span":{"begin":10,"end":16},"obj":"NN"},{"id":"T37792","span":{"begin":17,"end":19},"obj":"IN"},{"id":"T21845","span":{"begin":20,"end":30},"obj":"NN"},{"id":"T87196","span":{"begin":30,"end":31},"obj":"-COMMA-"},{"id":"T16269","span":{"begin":32,"end":37},"obj":"WDT"},{"id":"T23317","span":{"begin":38,"end":44},"obj":"RB"},{"id":"T90485","span":{"begin":45,"end":56},"obj":"VBZ"},{"id":"T49535","span":{"begin":57,"end":59},"obj":"PRP"},{"id":"T16896","span":{"begin":60,"end":62},"obj":"IN"},{"id":"T63209","span":{"begin":63,"end":71},"obj":"NN"},{"id":"T42025","span":{"begin":72,"end":79},"obj":"NN"},{"id":"T63465","span":{"begin":80,"end":85},"obj":"NN"},{"id":"T4468","span":{"begin":85,"end":86},"obj":"-COMMA-"},{"id":"T1830","span":{"begin":87,"end":94},"obj":"VBZ"},{"id":"T56636","span":{"begin":95,"end":98},"obj":"DT"},{"id":"T80263","span":{"begin":99,"end":110},"obj":"NN"},{"id":"T21297","span":{"begin":111,"end":113},"obj":"IN"},{"id":"T77941","span":{"begin":114,"end":121},"obj":"RB"},{"id":"T47145","span":{"begin":122,"end":134},"obj":"VBG"},{"id":"T48978","span":{"begin":135,"end":155},"obj":"NNS"},{"id":"T78349","span":{"begin":156,"end":166},"obj":"VBN"},{"id":"T84508","span":{"begin":167,"end":169},"obj":"IN"},{"id":"T99687","span":{"begin":170,"end":178},"obj":"NN"},{"id":"T94485","span":{"begin":179,"end":191},"obj":"NN"},{"id":"T8371","span":{"begin":192,"end":195},"obj":"MD"},{"id":"T70765","span":{"begin":196,"end":200},"obj":"RB"},{"id":"T19557","span":{"begin":201,"end":207},"obj":"VB"}],"relations":[{"id":"R37843","pred":"arg1Of","subj":"T18714","obj":"T10675"},{"id":"R59613","pred":"arg1Of","subj":"T18714","obj":"T37792"},{"id":"R69771","pred":"arg2Of","subj":"T21845","obj":"T37792"},{"id":"R38925","pred":"arg1Of","subj":"T18714","obj":"T87196"},{"id":"R46559","pred":"arg1Of","subj":"T18714","obj":"T16269"},{"id":"R78632","pred":"arg1Of","subj":"T90485","obj":"T23317"},{"id":"R80497","pred":"arg1Of","subj":"T18714","obj":"T90485"},{"id":"R82405","pred":"arg2Of","subj":"T49535","obj":"T90485"},{"id":"R44853","pred":"arg1Of","subj":"T90485","obj":"T16896"},{"id":"R46661","pred":"arg2Of","subj":"T63465","obj":"T16896"},{"id":"R81667","pred":"arg1Of","subj":"T63465","obj":"T63209"},{"id":"R13160","pred":"arg1Of","subj":"T63465","obj":"T42025"},{"id":"R63988","pred":"arg1Of","subj":"T1830","obj":"T4468"},{"id":"R71846","pred":"arg2Of","subj":"T19557","obj":"T1830"},{"id":"R93165","pred":"arg1Of","subj":"T80263","obj":"T56636"},{"id":"R55292","pred":"arg1Of","subj":"T80263","obj":"T21297"},{"id":"R1386","pred":"arg2Of","subj":"T48978","obj":"T21297"},{"id":"R1387","pred":"arg1Of","subj":"T47145","obj":"T77941"},{"id":"R1388","pred":"arg1Of","subj":"T48978","obj":"T47145"},{"id":"R1389","pred":"arg2Of","subj":"T48978","obj":"T78349"},{"id":"R1390","pred":"arg1Of","subj":"T78349","obj":"T84508"},{"id":"R1391","pred":"arg2Of","subj":"T94485","obj":"T84508"},{"id":"R1392","pred":"arg1Of","subj":"T94485","obj":"T99687"},{"id":"R1393","pred":"arg1Of","subj":"T80263","obj":"T8371"},{"id":"R1394","pred":"arg2Of","subj":"T19557","obj":"T8371"},{"id":"R1395","pred":"arg1Of","subj":"T19557","obj":"T70765"},{"id":"R1396","pred":"arg1Of","subj":"T80263","obj":"T19557"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T142","span":{"begin":20,"end":23},"obj":"Body_part"}],"attributes":[{"id":"A142","pred":"fma_id","subj":"T142","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T186","span":{"begin":20,"end":23},"obj":"Species"},{"id":"T191","span":{"begin":148,"end":155},"obj":"Species"}],"attributes":[{"id":"A186","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:57667"},{"id":"A187","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:35274"},{"id":"A188","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:12721"},{"id":"A189","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:11709"},{"id":"A190","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:11676"},{"id":"A191","pred":"ncbi_taxonomy_id","subj":"T191","obj":"NCBItxid:10239"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"831","span":{"begin":3,"end":9},"obj":"Chemical"},{"id":"830","span":{"begin":20,"end":25},"obj":"Species"}],"attributes":[{"id":"A831","pred":"pubann:denotes","subj":"831","obj":"MESH:D011134"},{"id":"A830","pred":"pubann:denotes","subj":"830","obj":"Tax:11676"}],"text":"ng glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ"}